ABSTRACT In a recent paper published in Cancer Cell, we identified subclinical cholestasis as an accessible imprint of gut dysbiosis predicting resistance to immune checkpoint blockade. Our work connects γ-glutamyl transferase, bile-acid remodeling, and MAdCAM-1 loss to compromised antitumor immunity, opening avenues f...
Anne-Laure Mallard de La Varende, M. Fidelle, G. Kroemer et al.· Oncoimmunology· 0 citations
The gut microbiome is a modifiable determinant of response to immune checkpoint inhibitors (ICI), positioning antibiotic exposure as a critical yet under-recognized risk factor for worse survival outcomes in immuno-oncology. As nearly 30% of ICI-treated patients receive antibiotics and indications of cancer immunothera...
Serena Porcari, L. Bolte, J. Björk et al.· Cancer Cell· 0 citations
INTRODUCTION
Identification of populations eligible for lung cancer screening (LCS) is a priority question in this field. The primary objective of this study was to quantify lung cancer prevalence after a first round of LCS among patients with history of atheromatous cardiovascular disease (aCVD) and tobacco exposure....
Elsa Armand, C. Buton, Caroline Caramella et al.· Respiratory medical research· 0 citations
Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. Many efforts have been made to stratify CRC cases, from investigating the genomic characteristics of the tumor to – more recently – considering the gut microbiome. Differences in the composition of the gut microbiome occur along...
Gianmarco Piccinno, Paolo Manghi, Luca Lazzari et al.· Scientific Reports· 0 citations
Whether a minimal circulating-protein signature anticipates incident cancer in patients with atheromatous cardiovascular disease exposed to tobacco is asked and estimates are conditional on the cancer frequency of this population, conditional on the cancer frequency of this population.
M. Fidelle, David Boulate, T. Pham et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.